公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
公司地址 5401 West Kennedy Boulevard, Suite 890, Tampa, FL, USA, 33609
電話號碼 +1 813 553-6680
傳真號碼 --
公司網頁 https://www.pacira.com
員工數量 829
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Brendan P. Teehan Chief Commercial Officer -- 21/01/2025
Mr. Frank D. Lee Director and Chief Executive Officer 美元 896.54K 26/02/2026
Mr. Jonathan Slonin Chief Medical Officer 美元 535.00K 29/04/2025
Mr. Shawn M. Cross Chief Financial Officer 美元 100.96K 26/02/2026
Mr. Daryl Gaugler Executive Vice President, Commercial Operations 美元 511.81K 21/01/2025
Ms. Lauren Riker Principal Accounting Officer and Senior Vice President, Finance 美元 374.56K 26/02/2026
Ms. Kristen Marie Williams Chief Administrative Officer and Secretary 美元 519.26K 29/04/2025
Ms. Krys Corbett Chief Business Officer -- 21/01/2025
 
董事會成員
董事會 職務 更新日期
Ms. Laura A. Brege Chairman of the Board 26/02/2026
Mr. Frank D. Lee Director and Chief Executive Officer 26/02/2026
Mr. Michael J. Yang Independent Director 26/02/2026
Dr. Marcelo Bigal, M.D.,PhD Independent Director 26/02/2026
Dr. Mark I. Froimson, M.D. Independent Director 26/02/2026
Ms. Alethia Young Independent Director 26/02/2026
Dr. Samit Hirawat, M.D. Independent Director 28/01/2026
Governor Christopher J. Christie Independent Director 26/02/2026
Mr. Abraham N. Ceesay, M.B.A. Independent Director 26/02/2026
Dr. Mark A. Kronenfeld, M.D. Independent Director 26/02/2026
 
所屬ETF (更新日期: 07/03/2026 04:57)
代號 名稱 佔比% 持有日期
VTWVVanguard Russell 2000 Value ETF0.07%31/01/2026
SCHBSchwab US Broad Market ETF™0.06%28/02/2026
AVUSAvantis US Equity ETF0.06%28/02/2026
RZGInvesco S&P SmallCap 600® Pure Gr ETF0.06%27/02/2026
FHLCFidelity MSCI Health Care ETF0.05%28/02/2026
ISMDInspire Small/Mid Cap ETF0.05%27/02/2026
FADFirst Trust Multi Cap Gr AlphaDEX® ETF0.04%26/02/2026
DFUSDimensional US Equity Market ETF0.03%27/02/2026
IWViShares Russell 3000 ETF0.03%28/02/2026
SMLVState Street® SPDR® USSmCapLowVolIndETF0.03%27/02/2026
PILLDirexion Daily Phrmctcl&MdclBl3XShrsETF0.03%26/02/2026
DFAUDimensional US Core Equity Market ETF0.02%27/02/2026
TILTFlexShares Mstar US Mkt Factors Tilt ETF0.02%27/02/2026
ISCViShares Morningstar Small-Cap Value ETF0.02%28/02/2026
OMFSInvesco Russell 2000® Dynamic Mltfct ETF0.02%27/02/2026
SPTMState StreetSPDRPortS&P1500CompStkMktETF0.02%27/02/2026
VFQYVanguard US Quality Factor ETF0.02%31/12/2025
AFSMFirst Trust Active Factor Small Cap ETF0.02%26/02/2026
QVMSInvesco S&P SmallCp 600 QVM Mlt-fctr ETF0.02%27/02/2026
DCORDimensional US Core Equity 1 ETF0.02%27/02/2026
  1    2   3    4    5    6  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.